FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120349675> ?p ?o ?g. }

• W2120349675 endingPage "56" @default.
• W2120349675 startingPage "48" @default.
• W2120349675 abstract "OBJECTIVE: To evaluate the efficacy of pancrealipase (PEZ) compared with placebo in the reduction of postprandial irritable bowel syndrome-diarrhoea (IBS-D). DESIGN: An intention to treat, double blind, randomised, crossover trial comparing PEZ to placebo for reduction of postprandial IBS-D. Patients had to recognise at least two different triggering foods, be willing to consume six baseline 'trigger meals' and again blinded with PEZ and placebo. Patients then chose which drug they preferred for another 25 meals. SETTING: Outpatient internal medicine practice clinic. PATIENTS: 255 patients were screened; 83 met the criteria, including 5 years of symptoms, recognised 'food triggers', no other identifiable cause for the symptoms, either a normal colonoscopy or barium enema while symptomatic and able to discontinue all anticholinergic medications. 69 patients were enrolled, 20 withdrew before randomisation, leaving 49 patients: 14 men, 35 women, mean age 52 years (SD 15.3). Over 60% had experienced symptoms for 11-30 years and 16% for more than 40 years. INTERVENTIONS: After completing six baseline meals, patients were randomised in blocks of four to receive either identical PEZ or a placebo for another six meals, and after a washout period of time received the alternative drug. MAIN OUTCOME MEASURES: The primary analysis was number of patients who chose PEZ over placebo for the extended use. RESULTS: Overall, 30/49 (61%) would have chosen PEZ (p=0.078), with first drug preference for PEZ at 0.002. Among the PEZ subgroup, PEZ use compared with placebo, demonstrated improvement in all symptoms (p≤0.001) for cramping, bloating, borborygami, urge to defecate, global pain and decrease stooling with increase in stool firmness. CONCLUSIONS: PEZ was found in a small group of patients to reduce postprandial IBS-D symptoms and deserves further evaluation." @default.
• W2120349675 created "2016-06-24" @default.
• W2120349675 creator A5024086017 @default.
• W2120349675 creator A5034890420 @default.
• W2120349675 creator A5036277404 @default.
• W2120349675 creator A5060782616 @default.
• W2120349675 date "2010-11-03" @default.
• W2120349675 modified "2023-10-14" @default.
• W2120349675 title "Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea" @default.
• W2120349675 cites W1481439037 @default.
• W2120349675 cites W1503435399 @default.
• W2120349675 cites W1532990492 @default.
• W2120349675 cites W1550945458 @default.
• W2120349675 cites W1566813966 @default.
• W2120349675 cites W1965551406 @default.
• W2120349675 cites W1965945782 @default.
• W2120349675 cites W1974433085 @default.
• W2120349675 cites W1975523098 @default.
• W2120349675 cites W1981220433 @default.
• W2120349675 cites W2003042917 @default.
• W2120349675 cites W2005763428 @default.
• W2120349675 cites W2006541740 @default.
• W2120349675 cites W2011073664 @default.
• W2120349675 cites W2016020050 @default.
• W2120349675 cites W2021569946 @default.
• W2120349675 cites W2022189473 @default.
• W2120349675 cites W2026508142 @default.
• W2120349675 cites W2031968580 @default.
• W2120349675 cites W2043710139 @default.
• W2120349675 cites W2045024342 @default.
• W2120349675 cites W2045572961 @default.
• W2120349675 cites W2053670834 @default.
• W2120349675 cites W2054209992 @default.
• W2120349675 cites W2060575412 @default.
• W2120349675 cites W2064683282 @default.
• W2120349675 cites W2065878875 @default.
• W2120349675 cites W2066083393 @default.
• W2120349675 cites W2067001312 @default.
• W2120349675 cites W2070768608 @default.
• W2120349675 cites W2087650645 @default.
• W2120349675 cites W2087856900 @default.
• W2120349675 cites W2091486179 @default.
• W2120349675 cites W2091843672 @default.
• W2120349675 cites W2095823529 @default.
• W2120349675 cites W2102445951 @default.
• W2120349675 cites W2110095273 @default.
• W2120349675 cites W2110649303 @default.
• W2120349675 cites W2132222381 @default.
• W2120349675 cites W2142350192 @default.
• W2120349675 cites W2146147731 @default.
• W2120349675 cites W2149072194 @default.
• W2120349675 cites W2153751304 @default.
• W2120349675 cites W2155620449 @default.
• W2120349675 cites W2166386674 @default.
• W2120349675 cites W23098967 @default.
• W2120349675 cites W2411444806 @default.
• W2120349675 cites W2414773982 @default.
• W2120349675 cites W2465388138 @default.
• W2120349675 cites W2468051791 @default.
• W2120349675 cites W2993228900 @default.
• W2120349675 doi "https://doi.org/10.1136/fg.2010.002253" @default.
• W2120349675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3009417" @default.
• W2120349675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22095308" @default.
• W2120349675 hasPublicationYear "2010" @default.
• W2120349675 type Work @default.
• W2120349675 sameAs 2120349675 @default.
• W2120349675 citedByCount "9" @default.
• W2120349675 countsByYear W21203496752012 @default.
• W2120349675 countsByYear W21203496752013 @default.
• W2120349675 countsByYear W21203496752016 @default.
• W2120349675 countsByYear W21203496752019 @default.
• W2120349675 crossrefType "journal-article" @default.
• W2120349675 hasAuthorship W2120349675A5024086017 @default.
• W2120349675 hasAuthorship W2120349675A5034890420 @default.
• W2120349675 hasAuthorship W2120349675A5036277404 @default.
• W2120349675 hasAuthorship W2120349675A5060782616 @default.
• W2120349675 hasBestOaLocation W21203496751 @default.
• W2120349675 hasConcept C121608353 @default.
• W2120349675 hasConcept C126322002 @default.
• W2120349675 hasConcept C142724271 @default.
• W2120349675 hasConcept C168563851 @default.
• W2120349675 hasConcept C1862650 @default.
• W2120349675 hasConcept C202953159 @default.
• W2120349675 hasConcept C204787440 @default.
• W2120349675 hasConcept C27081682 @default.
• W2120349675 hasConcept C2778199505 @default.
• W2120349675 hasConcept C2778271842 @default.
• W2120349675 hasConcept C2778435480 @default.
• W2120349675 hasConcept C2779306644 @default.
• W2120349675 hasConcept C3020110884 @default.
• W2120349675 hasConcept C526805850 @default.
• W2120349675 hasConcept C71924100 @default.
• W2120349675 hasConceptScore W2120349675C121608353 @default.
• W2120349675 hasConceptScore W2120349675C126322002 @default.
• W2120349675 hasConceptScore W2120349675C142724271 @default.
• W2120349675 hasConceptScore W2120349675C168563851 @default.
• W2120349675 hasConceptScore W2120349675C1862650 @default.
• W2120349675 hasConceptScore W2120349675C202953159 @default.

• next